EUVIMEDEUVIMED entdecken
EUVIMED · CrossrefZeitschrift

Prostate Cancer and Prostatic Diseases

ISSN 1365-7852 · Springer Science and Business Media LLC

Neueste Artikel

  1. Micro-ultrasound experience and clinically significant prostate cancer detection: a center-level analysis of the optimum randomized trial

    Melis Guer, Alon Lazarovich, Ferdinand Luger, Hannes Cash, Sangeet Ghai, L. Felipe Urdaneta-Salegui, Christian P. Pavlovich, Joseph Brito, Neal D. Shore, Julian P. Struck, Martin Schostak, Niklas Harland, Moisés Rodriguez-Socarrás, Wayne G. Brisbane, Giovanni Lughezzani, Harry Toledano, Mohammed Salah Ouertani, Petr Macek, Christopher Fung, Wendy Tu, Andreas Gusenleitner, Karsten Günzel, Peter F. Incze, Arvin K. George, José G. Pereira, Robert Jansen, Joseph Renzulli, Laurence Klotz, Adam Kinnaird

    Erschienen: 2026-10-28DOI: 10.1038/s41391-026-01171-y

  2. Risk factors for incidental prostate cancer following surgery for benign prostatic enlargement: A systematic review and meta-analysis

    Angelo Cormio, Akihiro Matsukawa, Alessandro Dematteis, Ahmed R. Alfarhan, Marcin Miszczyk, Navid Roessler, Abdulrahman S. Alqahtani, Stefano Mancon, Ichiro Tsuboi, Paweł Rajwa, Ugo Giovanni Falagario, Francesca Sanguedolce, Gian Maria Busetto, Carlo Bettocchi, Giuseppe Carrieri, Luigi Cormio, Andrea Benedetto Galosi, David D’Andrea, Takahiro Kimura, Shahrokh F. Shariat

    Erschienen: 2026-10DOI: 10.1038/s41391-026-01108-5

  3. Characterizing population-wide genomic risk distribution for development of a novel clinical-genomic risk system for prognostication in patients with clinically localized prostate cancer

    Udit Singhal, Ralph Jiang, James A. Proudfoot, Elizabeth Chase, Krithika Suresh, Elai Davicioni, Tudor Borza, Michael J. Zelefsky, Brian J. Davis, Brad J. Stish, R. Jeffrey Karnes, Stephen J. Freedland, Martha K. Terris, William J. Aronson, Matthew R. Cooperberg, Fabio Y. Moraes, Alejandro Berlin, Curtiland Deville, Nicholas G. Zaorsky, Soumyajit Roy, Angela Y. Jia, Jonathan E. Shoag, William C. Jackson, Daniel E. Spratt, Matthew Schipper, Todd M. Morgan, Robert T. Dess

    Erschienen: 2026-09DOI: 10.1038/s41391-025-01062-8

  4. Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patients

    Neal D. Shore, Christopher M. Pieczonka, Sean Heron, Mukaram Gazi, David J. Cahn, Laurence H. Belkoff, Aaron D. Berger, Brian Mazzarella, Joseph Veys, David Morris, Richard Bevan-Thomas, Alexander Engelman, Paul Dato, David R. Wise, Mary Kay Hardwick, Kerry W. Aradhya, Brandie Heald, Robert L. Nussbaum, Kathryn E. Hatchell, Brianna Bucknor, Edward D. Esplin, Sarah M. Nielsen

    Erschienen: 2026-06DOI: 10.1038/s41391-025-01013-3

  5. Outcomes of robot-assisted radical prostatectomy with novel robotic platforms vs da Vinci multiport systems: a systematic review and network meta-analysis

    Francesco Chierigo, Giuseppe Fallara, Massimiliano Depalma, Marco Tozzi, Alberto Quistini, Roberto Bianchi, Martina Maggi, Guglielmo Mantica, Cosimo De Nunzio, Rocco Damiano, Alessandro Veccia, Alessandro Antonelli, Francesco Porpiglia, Pierre Karakiewicz, Riccardo Autorino, Bernardo Rocco, Matteo Ferro

    Erschienen: 2026-03DOI: 10.1038/s41391-025-01023-1

  6. Quality of life in low-risk prostate cancer under active surveillance or following radical treatments: the START cohort study

    Rosalba Rosato, Stefano De Luca, Andrea Zitella, Fernando Munoz, Carlo Giuliano Baima, Maurizio Barale, Franco Bardari, Debora Beldì, Luca Bellei, Andrea Rocco Bellissimo, Diego Bernardi, Giorgio Biamino, Michele Billia, Roberto Borsa, Domenico Cante, Emanuele Castelli, Danilo Centrella, Enrico Checcucci, Devis Collura, Pietro Coppola, Ettore Dalmasso, Andrea Di Stasio, Michele Fiorio, Marco Gatti, Elisabetta Garibaldi, Giuseppe Girelli, Daniele Griffa, Alessia Guarneri, Stefano Guercio, Carlo Giuseppe Iorio, Roberto Migliari, Franco Montefiore, Maurizio Moroni, Giovanni Muto, Marco Oderda, Eva Pagano, Massimo Pasquale, Francesca Ponti di Sant’Angelo, Riccardo Rossi, Luca Ruggiero

    Erschienen: 2026-03DOI: 10.1038/s41391-025-01032-0

Jahrgänge

2026 · 1382025 · 2182024 · 1372023 · 1372022 · 1342021 · 1492020 · 912019 · 812018 · 722017 · 692016 · 672015 · 582014 · 582013 · 662012 · 632011 · 582010 · 672009 · 672008 · 732007 · 742006 · 742005 · 692004 · 732003 · 712002 · 852001 · 492000 · 1011999 · 1321998 · 461997 · 20

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.